Selvaraj Naicker
28Patents
12h-index
12Co-inventors
78Inventor score
Filing activity: May 5, 1988 → Aug 14, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7521421B2 | Deuterated cyclosporine analogs and methods of making the same | Emerging Cross-Sectional Technologies | 112 | Expired |
| US7538189B2 | Methods of making deuterated cyclosporin analogs | Emerging Cross-Sectional Technologies | 111 | Expired |
| US6884429B2 | Medical devices incorporating deuterated rapamycin for controlled delivery thereof | Human Necessities | 79 | Expired |
| US6503921B2 | Deuterated rapamycin compounds, methods and uses thereof | Human Necessities | 75 | Expired |
| US6342507B1 | Deuterated rapamycin compounds, method and uses thereof | Human Necessities | 63 | Expired |
| US6613739B1 | Deuterated cyclosporine analogs and their use as immunomodulating agents | Emerging Cross-Sectional Technologies | 61 | Expired |
| US6710053B2 | Deuterated rapamycin compounds, method and uses thereof | Human Necessities | 48 | Expired |
| US7060672B2 | Cyclosporin analog formulations | Chemistry; Metallurgy | 31 | Expired |
| US6998385B2 | Cyclosporine analogue mixtures and their use as immunomodulating agents | Emerging Cross-Sectional Technologies | 25 | Expired |
| US6939878B2 | Deuterated rapamycin compounds, method and uses thereof | Human Necessities | 22 | Expired |
| US8758725B2 | Perylenequinone derivatives and uses thereof | Chemistry; Metallurgy | 15 | Active |
| US6709873B1 | Method for production of antibodies to specific sites of rapamycin | Chemistry; Metallurgy | 15 | Expired |
| US7429562B2 | Cyclosporin analog formulations | Chemistry; Metallurgy | 9 | Expired |
| US6225323A | Activated iododerivatives for the treatment of cancer and AIDS | Chemistry; Metallurgy | 8 | Expired |
| US7332472B2 | Cyclosporine analogue mixtures and their use as immunomodulating agents | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7141648B2 | Synthesis of cyclosporin analogs | Emerging Cross-Sectional Technologies | 7 | Expired |
| US4935503A | Azidochlorination and diazidization of glycals | Chemistry; Metallurgy | 6 | Expired |
| US9765119B2 | Cyclosporine analogue mixtures and their use as immunomodulating agents | Emerging Cross-Sectional Technologies | 3 | Active |
| US7358229B2 | Deuterated cyclosporin analogs and their use as immunomodulating agents | Emerging Cross-Sectional Technologies | 3 | Expired |
| US10472394B2 | Cyclosporine analogue mixtures and their use as immunomodulating agents | Emerging Cross-Sectional Technologies | 2 | Active |
| US7829533B2 | Cyclosporin analog formulations | Chemistry; Metallurgy | 2 | Active |
| US6306871A | Activated iododerivatives for the treatment of cancer and AIDS | Chemistry; Metallurgy | 2 | Expired |
| USRE48226E1 | Cyclosporine analogue mixtures and their use as immunomodulating agents | General | 1 | Active |
| US8506931B2 | Perylenequinone derivatives and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US8747811B2 | Perylenequinone derivatives and uses thereof | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.